SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This study aims to test the effectiveness of using of SpeeDx Resistance Plus assay to guide
treatment of Neisseria gonorrhoeae (Ng) in a sexual health clinic setting.